We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHB icon
1
Schwab US Broad Market ETF
SCHB
$44.7B
$124M 10.87%
6,074,580
-302,268
-5% -$5.85M
FNDX icon
2
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
$79.8M 7.01%
3,551,373
-75,849
-2% -$1.61M
SCHF icon
3
Schwab International Equity ETF
SCHF
$69.3B
$79.6M 6.99%
4,077,598
-130,404
-3% -$2.44M
FNDF icon
4
Schwab Fundamental International Large Company Index ETF
FNDF
$26B
$68.8M 6.05%
1,932,676
-16,724
-0.9% -$568K
VTEB icon
5
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
$43.4M 3.82%
857,775
+77,474
+10% +$3.93M
PRF icon
6
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$39.2M 3.45%
1,019,526
-3,225
-0.3% -$117K
SPDW icon
7
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$38.8M 3.41%
1,082,339
-32,298
-3% -$1.11M
FNDB icon
8
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.49B
$30.5M 2.68%
1,382,841
-5,358
-0.4% -$112K
AVDV icon
9
Avantis International Small Cap Value ETF
AVDV
$20.3B
$30.1M 2.65%
457,307
+12,946
+3% +$807K
GSIE icon
10
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.12B
$27.8M 2.45%
812,043
-25,860
-3% -$856K
VWO icon
11
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$26M 2.28%
621,947
+72,771
+13% +$2.97M
INTF icon
12
iShares International Equity Factor ETF
INTF
$3.75B
$25.2M 2.22%
844,576
-18,118
-2% -$518K
AAPL icon
13
Apple
AAPL
$4.67T
$23.9M 2.1%
139,307
+1,577
+1% +$287K
AVUV icon
14
Avantis US Small Cap Value ETF
AVUV
$31.3B
$21.5M 1.89%
228,973
+44,538
+24% +$3.94M
XLK icon
15
State Street Technology Select Sector SPDR ETF
XLK
$121B
$20.7M 1.82%
199,228
-4,376
-2% -$443K
FNDA icon
16
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$19.8M 1.74%
695,858
-588
-0.1% -$16K
SPTM icon
17
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$19.5M 1.71%
303,342
-29,706
-9% -$1.81M
GSLC icon
18
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$19.4M 1.71%
186,974
-9,737
-5% -$960K
VGT icon
19
Vanguard Information Technology ETF
VGT
$147B
$18.6M 1.63%
283,328
-11,392
-4% -$722K
VEU icon
20
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
$16.4M 1.44%
279,130
-2,588
-0.9% -$146K
FNDE icon
21
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.2B
$14.2M 1.25%
513,245
+88,887
+21% +$2.4M
DISV icon
22
Dimensional International Small Cap Value ETF
DISV
$5.25B
$12M 1.06%
441,453
-9,082
-2% -$234K
PRFZ icon
23
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.83B
$11.6M 1.02%
296,235
-923
-0.3% -$34.4K
XLV icon
24
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$11.4M 1%
77,335
-1,873
-2% -$269K
MSFT icon
25
Microsoft
MSFT
$3.81T
$10.8M 0.95%
25,562
+6,042
+31% +$2.45M

Similar funds

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.